TY  - JOUR
AU  - Dagg, Rebecca A
AU  - Zonderland, Gijs
AU  - Lombardi, Emilia Puig
AU  - Rossetti, Giacomo G
AU  - Groelly, Florian J
AU  - Barroso, Sonia
AU  - Tacconi, Eliana M C
AU  - Wright, Benjamin
AU  - Lockstone, Helen
AU  - Aguilera, Andrés
AU  - Halazonetis, Thanos D
AU  - Tarsounas, Madalena
PY  - 2021
DO  - 10.1038/s41467-021-25215-0
UR  - http://hdl.handle.net/10668/18372
T2  - Nature communications
AB  - BRCA1 or BRCA2 germline mutations predispose to breast, ovarian and other cancers. High-throughput sequencing of tumour genomes revealed that oncogene amplification and BRCA1/2 mutations are mutually exclusive in cancer, however the molecular...
LA  - en
KW  - BRCA1 Protein
KW  - BRCA2 Protein
KW  - Breast Neoplasms
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cell Survival
KW  - Cells, Cultured
KW  - Cyclin-Dependent Kinase Inhibitor p21
KW  - DNA Damage
KW  - Female
KW  - Gene Expression Profiling
KW  - HeLa Cells
KW  - Humans
KW  - Oncogenes
KW  - Ovarian Neoplasms
KW  - RNA-Seq
KW  - Transcription, Genetic
KW  - beta Catenin
TI  - A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells.
TY  - research article
VL  - 12
ER  -